Trials / Completed
CompletedNCT00419484
Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (planned)
- Sponsor
- Dokkyo Medical University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
We want to investigate the effects of pioglitazone on cardiovascular events in Japanese patients with type 2 diabetes.
Detailed description
Primary composite endpoints: Cardiovascular death Non-fatal myocardial infarction and angina Non-fatal stroke Renal failure (hemodialysis/doubling of serum creatinine) Secondary endpoints: urinary albumin excretion diabetic retinopathy hyperlipidemia hypertension gout
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pioglitazone |
Timeline
- Start date
- 2004-03-01
- Completion
- 2008-07-01
- First posted
- 2007-01-08
- Last updated
- 2007-01-08
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00419484. Inclusion in this directory is not an endorsement.